Zweier, J
These open, sometimes spirited conversations have helped move GLP-1 into the broader wellness dialogue, making it a touchpoint for anyone seeking to balance innovation with personal health priorities
GLP-1 + CIRUGA 7 MIN DE LECTURA ACTUALIZADO MAYO 2026 GLP-1 (Ozempic, Wegovy) y Bypass Gstrico: Complementarios o Sustitutos
Casas AI, Dao VT, Daiber A, Maghzal GJ, Di Lisa F, Kaludercic N, Leach S, Cuadrado A, Jaquet V, Seredenina T, Krause KH, Lpez MG, Stocker R, Ghezzi P, Schmidt HH (2015) Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications
Participants who had taken GLP-1s for 2 or 2.5 years before discontinuing use for the remainder of the study also saw a significant reduction in risk of 7% and 15%, respectively